ArticleNature chemistry2026
Copper-catalysed site-selective arylation of pyrazoles.
Article in Nature chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
6 authors.
Funding
Abstract
A major challenge in late-stage functionalization is the selective N-arylation of unsymmetric pyrazoles, five-membered heterocycles with two adjacent nitrogen atoms, which are prevalent in blockbuster medicines and bioactive molecules. Traditional cross-coupling methods usually favour one type of regioisomer, limiting access to complementary structures that could accelerate drug discovery and streamline structure-activity relationship studies. Here we show that copper catalysis harnesses arynes to achieve switchable arylation of pyrazoles under mild conditions. By tuning Cu-pyrazole coordination, we direct arylation to either nitrogen atom, unlocking selectivity between two similar sites. Mechanistic studies reveal how steric and electronic effects govern regioselectivity, transforming an inherently unpredictable process into a blueprint for selective recognition of N-N linkages. This approach establishes a general strategy for controlling site selectivity in nitrogen-rich heterocycles and highlights the use of strained intermediates in late-stage diversification.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.